MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Respiratory Disorders

Discover actionable biomarkers across the spectrum with non-invasive methods

The National Center for Health Statistics estimates that more than 25 million people in the U.S. have asthma and approximately 14.8 million adults have been diagnosed while 12 million remain undiagnosed.1,2 Respiratory diseases pose a tremendous burden on society and healthcare systems globally, with the World Health Organization reporting that the top five respiratory diseases account for 17.4% of deaths.

While asthma has a low fatality rate, it affects 150 million people worldwide and is the most prevalent chronic childhood disease. Still there are more respiratory disorders like chronic obstructive pulmonary disease (COPD), chronic bronchitis, lung cancer, cystic fibrosis, pneumonia, plural effusion and infectious diseases like influenza and COVID-19 where metabolomics is useful in helping to decode disease mechanisms and more.

TALK WITH AN EXPERT
See More Solutions
Unlock disease mechanisms and support patient stratification

More understanding is needed about the aspects of disease occurrence and severity in respiratory disorders. Global metabolomics can be applied to cultured cells, tissues from model organisms, and patient biopsies to discover metabolic drivers of processes such as cell death and malignant transformation. These insights can be translated into actionable biomarkers through follow-on targeted assays.

Build diagnostics and targets

Respiratory disorders are varied and involve distinct pathways. A narrow focus isn’t enough to understand the intricacy of these diseases in order to develop effective drug targets. Leveraging global metabolomics as a wide-angle tool will support the development of non-invasive diagnostics and therapeutics that have the capability to improve the lives of patient.

1. Bloom B, Jones LI, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(258). 2013.

2. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(260). 2014.

3. https://www.who.int/respiratory/publications/strategy/en/index1.html#:~:text=According%20to%20the%20WHO%20World,Adjusted%20Life%20Years%20(DALYs).

Study Design

Data Interpretation

Our Platform

Learn More

Related Resources

See All Resources
Driving COVID-19 Research Forward

Driving COVID-19 Research Forward

Biotech / Pharmaceutical, Clinical Development, COVID-19, Discovery & Target Selection, Global Metabolomics, Infectious Disease, Lead Candidate Selection, Preclinical, Targeted Assays, Webinars
Reflections of the Human Gut Microbiome in the Blood Metabolome

Reflections of the Human Gut Microbiome in the Blood Metabolome

Gastrointestinal, Global Metabolomics, Microbiome, Multi-Omics Integration, Targeted Assays, Webinars
Answering Common Questions about Metabolomics

Answering Common Questions about Metabolomics

Clinical Development, Global Metabolomics, Targeted Assays, Webinars
Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data
or Talk With an Expert

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.